Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-18T16:53:04.106Z Has data issue: false hasContentIssue false
  • English
  • Français

Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review

Published online by Cambridge University Press:  11 June 2014

Bridgette Johnson  and
Scott Nichols
Bridgette Johnson
Affiliation:
Biological Sciences Major, University of California–Davis, Davis, California
Scott Nichols*
Affiliation:
Department of Behavioral Health, Enloe Medical Center, Chico, California
*
Address correspondence and reprint requests to: Scott Nichols, Medical Director, Behavioral Health, Enloe Medical Center, 560 Cohasset Road, Chico, California 95926. E-Mail: snichols.md@gmail.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Pseudobulbar affect/emotional incontinence is a potentially disabling condition characterized by expressions of affect or emotions out of context from the normal emotional basis for those expressions. This condition can result in diagnostic confusion and unrelieved suffering when clinicians interpret the emotional expressions at face value. In addition, the nomenclature, etiology, and treatment for this condition remain unclear in the medical literature.

Method:

We report the case of a 60-year-old woman with multiple sclerosis who was referred to an inpatient psychiatry unit with complaints of worsening depression along with hopelessness, characterized by unrelenting crying. Our investigation showed that her symptoms were caused by pseudobulbar affect/emotional incontinence stemming from multiple sclerosis.

Results:

The patient's history of multiple sclerosis and the fact that she identified herself as depressed only because of her incessant crying suggested that her symptoms might be due to the multiple sclerosis rather than to a depressive disorder. Magnetic resonance imaging demonstrated a new plaque consistent with multiple sclerosis lateral to her corpus callosum. Her symptoms resolved completely within three days on valproic acid but returned after she was cross-tapered to dextromethorphan plus quinidine, which is the FDA-approved treatment for this condition.

Significance of Results:

This case provides important additional information to the current literature on pseudobulbar affect/emotional incontinence. The existing literature suggests a selective serotonin reuptake inhibitor (SSRI) and dextromethorphan/quinidine (Nuedexta) as first-line treatments; however, our patient was taking an SSRI at the time of presentation without appreciable benefit, and her symptoms responded to valproic acid but not to the dextromethorphan/quinidine. In addition, the case and the literature review suggest that the current nomenclature for this constellation of symptoms can be misleading.

Keywords

Pseudobulbar affectEmotional incontinencePathological laughing and cryingEmotional dysregulationValproic acid
Type
Case Reports
Information
Palliative & Supportive Care , Volume 13 , Issue 6 , December 2015 , pp. 1797 - 1801
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (APA) (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, Washington.Google Scholar
Andersen, G., Vestergaard, K. & Riis, J.O. (1993). Citalopram for post-stroke pathological crying. Lancet, 342, 837–839.CrossRefGoogle ScholarPubMed
Andersen, G., Ingeman-Nielsen, M., Vestergaard, K., et al. (1994). Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke, 25, 1050–1052.CrossRefGoogle ScholarPubMed
Cottrell, S.S. & Wilson, S.A.K. (1926). The affective symptomatology of disseminated sclerosis. Journal of Neurological Psychopathology, 7, 1–30.CrossRefGoogle ScholarPubMed
Darwin, C. (1872). The expression of the emotions in man and animals. New York and London: D. Appleton and Company. Cited at http://en.wikipedia.org/wiki/Pseudobulbar_affect.CrossRefGoogle Scholar
Derex, L., Ostrowsky, K., Nighoghossian, N., et al. (1997). Severe pathological crying after left anterior choroidal artery infarct: Reversibility with paroxetine treatment. Stroke, 28, 1464–1466.CrossRefGoogle ScholarPubMed
Feinstein, A., Feinstein, K., Gray, T., et al. (1997). Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Archives of Neurology, 54(9), 1116–1121.CrossRefGoogle ScholarPubMed
Kaufman, D.M. (2007). Clinical neurology for psychiatrists, 6th ed. Philadelphia: Saunders/Elsevier.Google Scholar
Miller, A., Pratt, H. & Schiffer, R.B. (2011). Pseudobulbar affect: The spectrum of clinical presentations, etiologies and treatments. Expert Review of Neurotherapeutics, 11(7), 1077–1088.CrossRefGoogle ScholarPubMed
Nahas, Z., Arlinghaus, K.A., Kotrla, K.J., et al. (1998). Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. Journal of Neuropsychiatry and Clinics Neurosciences, 10, 453–455.CrossRefGoogle ScholarPubMed
Parvizi, J., Anderson, S.W., Martin, C.O., et al. (2001). Pathological laughter and crying: A link to the cerebellum. Brain, 124, 1708–1719.CrossRefGoogle ScholarPubMed
Pioro, E.P., Brooks, B.R., Cummings, J., et al. (2010). Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Annals of Neurology, 68(5), 693–702.CrossRefGoogle ScholarPubMed
Poeck, K. (1985). Pathophysiology of emotional disorders associated with brain damage. In Handbook of clinical neurology, Vol. 3. Vinken, P.J. & Bruyn, G.W. (eds.), pp. 343–367. Amsterdam: Elsevier.Google Scholar
Robinson, R.G. (1997). Neuropsychiatric consequences of stroke. Annual Review of Medicine, 48, 217–229.CrossRefGoogle ScholarPubMed
Ross, E.D. & Stewart, R.S. (1987). Pathological display of affect in patients with depression and right frontal brain damage: An alternative mechanism. The Journal of Nervous and Mental Disease, 175, 165–172.CrossRefGoogle ScholarPubMed
Sandyk, R. & Gillman, M.A. (1985). Nomifensine for emotional incontinence in the elderly. Clinical Neuropsychopharmacology, 8, 377–378.CrossRefGoogle ScholarPubMed
Schiffer, R.D., Herndon, R. & Rudick, R. (1985). Treatment of pathological laughter and weeping with amitriptyline. The New England Journal of Medicine, 312, 1480–1482.CrossRefGoogle ScholarPubMed
Udaka, F., Yamao, S., Nagata, H., et al. (1984). Pathologic laughing and crying treated with levodopa. Archives of Neurology, 41, 1095–1096.CrossRefGoogle ScholarPubMed
van Hilten, J.J., Buruma, O.J., Kessing, P., et al. (1988). Pathologic crying as a prominent behavioral manifestation of central pontine myelinolysis [letter]. Archives of Neurology, 45, 936.CrossRefGoogle ScholarPubMed
Wilson, S.A.K. (1924). Some problems in neurology, II: Pathological laughing and crying. Journal of Neurological Psychopathology, 4(16), 299–333.CrossRefGoogle Scholar